OPEN Health has announced the appointment of Matt D’Auria as its new chief executive officer (CEO).
D’Auria brings more than 25 years of experience in medical affairs and scientific commercialisation to the role, which he takes on after serving as CEO of the Healthcare Consultancy Group (HCG).
D’Auria also previously held agency leadership roles at Envision Communications and Syneos Health, and served in oncology marketing and sales positions at AstraZeneca earlier in his career.
Dave King, chairman of OPEN Health’s board of directors, said: “Matt’s global experience, commitment to scientific excellence, and innovation mindset align perfectly with OPEN Health’s core values and growth strategy.
“We are confident that he will lead us to even greater heights, and we are excited for the future under his leadership.”
D’Auria added that he is “truly honoured to lead OPEN Health at this time”.
In his latest role, D’Auria will focus on refining and deploying an innovation and growth strategy at OPEN Health. He succeeds Vivid Sehgal, interim CEO, who will be joining the company’s board as a non-executive director.